Gastrointestinal Stromal Tumors

Some of the drugs in the pipeline for colorectal cancer therapeutics are Lonsurf, CYRAMZA (ramucirumab), TS-1/Teysuno, CPP-1X (eflornithine hydrochloride), MelCancerVac, Xilonix, and Nintedanib. There are various medications such as chemotherapy drugs, immunotherapy, and leucovorin (chemoprotectant) that can be used to treat colorectal cancer. Chemotherapy drugs for the treatment of colorectal cancer include anti-metabolites such as fluorouracil and capecitabine. Monoclonal antibodies used in immunotherapy as part of the treatment of colorectal cancer are bevacizumab, cetuximab, and panitumumab. Bevacizumab (Avastin®), ramucirumab (Cyramza®), and ziv-aflibercept (Zaltrap®) are drugs used for colon cancer that target vascular endothelial growth factor (VEGF). VEGF is a protein that helps tumors form new blood vessels to get nutrients (a process known as angiogenesis).

Analysis from business intelligence provider GBI Research - Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - states that the Colorectal Cancer (CRC) treatment market value will increase at a moderate Compound Annual Growth Rate (CAGR) of 1.8%, from $8.3 billion in 2013 to $9.4 billion by 2020.Bevacizumab and ramucirumab are monoclonal antibodies, which are man-made versions of immune system proteins. These drugs are typically combined with chemo to treat advanced colon cancer.
 
Ziv-aflibercept is a different kind of protein that targets VEGF. It can also be combined with chemo to treat advanced colon cancer, although it was approved to be combined only with a certain chemo combination.These drugs are given as infusions into a vein (IV) every 2 or 3 weeks.
 
 
  • Drugs used for Pancreatic & Colorectal Cancer
  • Current therapeutic approaches
  • Novel therapeutic antibodies to treat colorectal cancer
  • Colorectal Cancer Therapeutics Market: Global Industry Analysis
  • Adverse drug reactions

Related Conference of Gastrointestinal Stromal Tumors

June 29-July 01, 2017

International Conference on Hematology and Oncology

Bangkok, Thailand
July 17-19, 2017

19th Euro Congress on Cancer Science and Therapy

Lisbon, Portugal
July 27-28, 2017

4th International Conference and Exhibition on Medical Physics and Biophysics

Rome, Italy - Hotel Holiday Inn Rome
August 28-30, 2017

International Oncologist & Diagnostics Conference

Brussels, Belgium
October 18-20, 2017

25th World Congress on Cancer Science and Therapy

Baltimore, Maryland, USA
October 19-20, 2017

15th World Oncologists Annual Conference

New York ,USA
Oct 19-21, 2017

25th World Cancer Conference

Rome, Italy
October 26-28, 2017

9th International Conference on Biomarkers

Osaka,Japan
November 06-08, 2017

2nd International Congress on Epigenetics & Chromatin

Frankfurt, Germany (H4 Hotel Frankfurt Messe)
November 09-10, 2017

10th World Hematology and Oncology Congress

Vienna, Austria
November 16-17, 2017

World Cancer Meeting

Melbourne, Australia
November 20-22, 2017

14th Asia Pacific
Oncologists Annual Meeting

Melbourne, Australia
November 23-24, 2017

Global Meeting on Molecular & Cancer Biomarkers

Dubai, UAE
November 27-28, 2017

26th World Cancer Convention

Dubai, UAE
November 27- 28, 2017

International Conference on Cancer Diagnostics

Dubai, UAE
December 07-08, 2017

9th World Biomarkers Congress

Madrid, Spain
March 14-16, 2018

Global Summit on Oncology & Cancer

Singapore
May 24-25, 2018

22nd Global Annual Oncologists Meeting

Osaka, Japan

Gastrointestinal Stromal Tumors Conference Speakers

Recommended Sessions

Related Journals

Are you interested in